Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 845 of 6351
-
New hope for cervical cancer: drug combo targets tumors resistant to immunotherapy
Disease control OngoingAlthough immune checkpoint inhibitors (ICIs) provide a durable response in multiple tumor types, relapse occurs in most patients with solid tumor. However, the benefits of retreatment with ICIs remains controversial. In some studies, retreatment with ICIs has exhibited encouragin…
Phase 2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
A free app might sharpen hearing after cochlear implants — trial puts it to the test
Symptom relief Recruiting nowThe purpose of this study is to compare the effectiveness of a free computer-based auditory training program, Sound Success (Advanced Bionics, Valencia, CA), with the current standard of care of patient-directed auditory training in improving common measures of speech recognition…
Sponsor: Mayo Clinic • Aim: Symptom relief
Last updated Aug 07, 2026 00:00 UTC
-
Parkinson's breakthrough? stem cells show promise in early trial
Disease control CompletedIndication: Patients who were diagnosed with Parkinson's disease ≥ 5 years ago. Purpose: To find the maximum tolerable dose and evaluate the safety and exploratory efficacy of allogenic embryonic stem cell-derived A9 dopamine progenitor cell (A9-DPC) therapy in patients who were…
Phase 1/2 • Sponsor: S.Biomedics Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
New pill could tame focal seizures when other drugs fail
Disease control Recruiting nowThe X-TOLE3 Phase 3 clinical trial is a randomized, double-blind, placebo-controlled study that will evaluate the clinical efficacy, safety and tolerability of XEN1101 administered as adjunctive therapy in focal-onset seizures.
Phase 3 • Sponsor: Xenon Pharmaceuticals Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
New drug cocktail shows promise against rare blood cancer
Disease control Recruiting nowThis is a prospective, single arm, single center study to evaluate the efficacy and safety of Duvelisib combined with Chidamide in the treatment of newly diagnosed peripheral T-cell lymphoma.
Phase 2 • Sponsor: Liling Zhang • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
New CLL strategy: give extra drug only to those who still have cancer cells
Disease control OngoingBruton's tyrosine kinase inhibitors (BTKi), anti-CD20 antibodies, and the B cell lymphoma 2 inhibitor (BCL-2i) venetoclax are drug classes used to treat patients with chronic lymphocytic leukemia/small lymphocytic leukemia (CLL/SLL). Anti-CD20 therapy may not be required for all …
Phase 2 • Sponsor: Weill Medical College of Cornell University • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
New drug combo shows promise for Tough-to-Treat uterine cancer
Disease control OngoingThis is an open-label, multi-center Phase II study of cadonilimab (AK104) combined with lenvatinib in patients with advanced endometrial cancer. The primary objective is to evaluate objective response rate of cadonilimab plus lenvatinib.
Phase 2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Could a cancer pill stop debilitating nosebleeds? new trial hopes so.
Disease control OngoingDuring the Efficacy Study (Part B), the investigators will study whether Pazopanib, taken daily for 24 weeks, will reduce the severity of nose bleeds in patients with hereditary hemorrhagic telangiectasia (HHT). Patients will either be provided active drug or a placebo \[sugar - …
Phase 2/3 • Sponsor: Cure HHT • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
Heart scan may spot hidden brain disease
Diagnosis By invitation onlyThe purpose of the study is to investigate the use of a special radioactive drug called 123I-MIBG and myocardial MIBG scintigraphy. This scan may be able to help determine who may have a certain kind of neurologic disorder called Lewy Body Disease. The overall purpose of this st…
Phase 4 • Sponsor: Mayo Clinic • Aim: Diagnosis
Last updated Aug 01, 2026 00:00 UTC
-
Could a monthly shot cut heart failure deaths? major trial underway
Disease control OngoingThis study will be done to see if ziltivekimab can be used to treat people living with heart failure and inflammation. Participants will either get ziltivekimab or placebo. Participants will get study medicine for once-monthly injections either in a pre-filled syringe to inject t…
Phase 3 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC
-
Could a common antibiotic cut deaths in advanced HIV?
Disease control Recruiting nowA double blinded, placebo-controlled, multicenter trial to evaluate effectiveness of azithromycin prophylaxis on mortality in advanced HIV.
Phase 3 • Sponsor: Population Health Research Institute • Aim: Disease control
Last updated Jun 26, 2026 13:18 UTC
-
Nanoparticles boost radiation to fight advanced cancer in new trial
Disease control Recruiting nowThis phase I/II trial studies the side effects and possible benefits of NBTXR3, radiation therapy, Anti PD-1 / PD-L1 in treating patients with solid tumor that has spread to the lung (lung metastases) and/or liver (liver metastases). NBTXR3 may help make tumor cells more sensitiv…
Phase 1/2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Aug 01, 2026 00:00 UTC
-
Can a doula checklist save Mothers' lives? new study aims to find out
Symptom relief OngoingThis study will develop and test an intervention, called the Well-Mama intervention, which includes the use of a checklist by Community Doula Navigators to support pregnant women. Participants will be randomized to either receive standard perinatal care or standard perinatal care…
Sponsor: Northwestern University • Aim: Symptom relief
Last updated Aug 23, 2026 00:00 UTC
-
Can a Melanin-Sensing oximeter end hidden oxygen reading bias?
Diagnosis CompletedPurpose: Investigate the safe wearability and basic functionality - epidermal melanin concentration and blood oxygen estimation - of our developed device: Melanin-Adjusted Blood Oxygen Sensor (MABOS) Participants: Healthy adults 18-65 years of age Procedures (methods): The inve…
Sponsor: University of North Carolina, Chapel Hill • Aim: Diagnosis
Last updated Aug 16, 2026 00:00 UTC
-
New radioactive therapy could delay chemotherapy for prostate cancer
Disease control OngoingThe purpose of this study is to evaluate the efficacy of \[177Lu\]Lu-PSMA-617 over a change of androgen receptor-directed therapy (ARDT) treatment in prolonging radiographic progression free survival (rPFS) in Chinese metastatic castration-resistant prostate cancer patients, who …
Phase 2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Donor immune cells take on tough leukemia in early trial
Disease control Recruiting nowThe objective of this study is to demonstrate that cytokine-induced memory-like natural killer cells can be generated from donor cells and infused safely into patients with relapsed or refractory acute myeloid leukemia (AML). A secondary objective is to assess efficacy of the CIM…
Phase 1/2 • Sponsor: Children's Hospital Medical Center, Cincinnati • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
Weight loss warning: new study aims to catch cancer sooner
Diagnosis Recruiting nowUnintentional weight loss (UWL) is commonly associated with a wide variety of diseases and there is still no valid diagnostic pathway for evaluating UWL. When detecting UWL coupled with GRAIL Galleri testing, (an investigational pan-cancer early detection test), it is thought tha…
Sponsor: Case Comprehensive Cancer Center • Aim: Diagnosis
Last updated Jun 27, 2026 13:06 UTC
-
New drug cocktail aims to shrink Hard-to-Treat lung tumors
Disease control Recruiting nowThis phase II Lung-MAP treatment trial test the combination of targeted drugs (capmatinib, osimertinib, and/or ramucirumab) in treating patients with non-small cell lung cancer that may have spread from where it first started to nearby tissue, lymph nodes, or distant parts of the…
Phase 2 • Sponsor: SWOG Cancer Research Network • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Digital nurse companion: could an app ease the burden of chronic illness?
Symptom relief CompletedA randomized controlled trial with non-communicable disease patients from two medical hospitals in Norway will be recruited prior to hospital discharge. The intervention group will participate in a 42-day nurse-assisted eHealth intervention "eHealth@ Hospital-2-Home". The interve…
Sponsor: University of Stavanger • Aim: Symptom relief
Last updated Aug 16, 2026 00:00 UTC
-
Pharmacists on the frontline: new study aims to cut opioid overdose deaths after prison
Disease control CompletedThe purpose of this study is to investigate the impact of a pharmacist-led intervention to expand access to medications for opioid use disorder (MOUD) on racial/ethnic differences in opioid-related overdose among individuals diagnosed with opioid use disorder (OUD) currently inca…
Sponsor: University of Arkansas • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC